VIR
Vir Biotechnology, Inc.
NASDAQ · USHealthcareBiotechnology
$9.23-2.12%
Price as of Jul 20, 2026
VIR profitability
Vir Biotechnology, Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 275.2%
- EBITDA margin
- -669.6%
- EBIT margin
- -704.9%
- Net margin
- -676.0%
- Free cash flow margin
- -679.2%
Returns
- Return on equity
- -54.5%
- Return on assets
- -43.2%
- Return on invested capital
- -50.8%
- Asset turnover
- 0.06x
Cash efficiency
- Cash from operations
- -$446.1M
- Cash per share
- $2.80
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.